THE EFFECTS OF 2 CALCIUM-ANTAGONISTS (NIFEDIPINE AND VERAPAMIL) ON RENAL-FUNCTION IN SHEEP

被引:1
作者
VERSCHUER, L
YESBERG, NE
HENDERSON, M
DALLEMAGNE, C
CROSS, RB
机构
来源
QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES | 1988年 / 73卷 / 04期
关键词
D O I
10.1113/expphysiol.1988.sp003173
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
引用
收藏
页码:533 / 538
页数:6
相关论文
共 50 条
[41]   NEGATIVE INOTROPIC ACTIVITY OF THE CALCIUM-ANTAGONISTS ISRADIPINE, NIFEDIPINE, DILTIAZEM, AND VERAPAMIL IN DISEASED HUMAN MYOCARDIUM [J].
SCHWINGER, RHG ;
BOHM, M ;
ERDMANN, E .
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (02) :S185-S187
[43]   DIFFERENTIAL THERAPY WITH CALCIUM-ANTAGONISTS IN PULMONARY-HYPERTENSION SECONDARY TO COPD - HEMODYNAMIC-EFFECTS OF NIFEDIPINE, DILTIAZEM, AND VERAPAMIL [J].
GASSNER, A ;
SOMMER, G ;
FRIDRICH, L ;
MAGOMETSCHNIGG, D ;
PRIOL, A .
CHEST, 1990, 98 (04) :829-834
[44]   CLINICAL EFFECTS OF INTRAVENOUS NIFEDIPINE ON RENAL-FUNCTION [J].
YOKOYAMA, S ;
KABURAGI, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (01) :67-71
[45]   INHIBITORY EFFECTS OF VERAPAMIL, NIFEDIPINE AND NICARDIPINE ON HISTAMINE-INDUCED CONTRACTIONS OF DISEASED GALLBLADDER - ANTIHISTAMINE ACTION OF CALCIUM-ANTAGONISTS [J].
JANKOVIC, S ;
BELESLIN, DB .
IUGOSLAVICA PHYSIOLOGICA ET PHARMACOLOGICA ACTA, 1990, 26 (01) :95-99
[46]   EFFECTS OF STEVIOSIDE AND VERAPAMIL ON RENAL-FUNCTION IN RATS [J].
SAINATI, AR ;
MELIS, MS ;
MACIEL, RE .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1986, 19 (4-5) :A532-A532
[47]   EFFECTS OF CALCIUM-ANTAGONISTS ON HYPERTENSION AND DIASTOLIC FUNCTION [J].
OPIE, LH ;
COMMERFORD, PJ ;
ADNAMS, C .
SOUTH AFRICAN MEDICAL JOURNAL, 1989, 76 (03) :89-92
[48]   RENAL ACTIONS OF CALCIUM-ANTAGONISTS [J].
ABE, Y ;
OKAHARA, T ;
YUKIMURA, T .
JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 :P43-P43
[49]   RENAL PROTECTION WITH THE CALCIUM-ANTAGONISTS [J].
NEUMAYER, HH ;
KUNZENDORF, U .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 :S11-S18
[50]   RENAL ACTIONS OF CALCIUM-ANTAGONISTS [J].
STERZEL, RB .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 :S17-S22